Skip to search formSkip to main contentSkip to account menu

11-Dehydro thromboxane beta 2:MRat:24H:Urine:Qn

Known as: Thromboxane beta 2 [Mass/time] in 24 hour Urine, 11-Dehydro thromboxane beta 2 [Mass/time] in 24 hour Urine, TXB2 24H Ur-mRate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A hallmark pathological feature of the Alzheimer's disease (AD) brain is the presence of senile plaques, which comprise amyloid… 
2010
2010
This study investigated the efficacy of terutroban, a specific thromboxane/prostaglandin endoperoxide receptor antagonist, on… 
2009
2009
The effects of maternal n-6 and n-3 fatty acid (FA) supplementation on hatched chick tissue FA profile, antioxidant status, and… 
2007
2007
Thromboxane A2 (TxA2) is assumed to contribute to the development of diabetes complications, including nephropathy. We… 
1998
1998
BACKGROUND Serum triacylglycerols (TG), VLDL, HDL, fatty acid and eicosanoid spectrum are among the factors determining the risk… 
1994
1994
We investigated the possibility that the selective angiotensin II type 1 (AT1) receptor antagonist, losartan, interacts with… 
1991
1991
Quantitative analysis of thromboxane (TX) levels in vivo is a useful approach to clerify clinical feature of cardiovascular… 
1986
1986
There is evidence that tumors may stimulate platelet aggregation, causing release of thromboxane A2. Thromboxane A2 may…